Sulfocoumarins as a promising class of cancer-associated carbonic anhydrase inhibitors

Research of Prof. R. Žalubovskis group (LIOS) and scientists from Serbia (Institute for Biological Research “Sinisa Stankovic”, State University of Novi ) has been published in European Journal of Pharmaceutical Sciences (IF 3.532, 2018) on sulfocoumarins as a promising class of cancer-associated carbonic anhydrase inhibitors:

Ana Podolski-Renić,Jelena Dinić,Tijana Stanković, Mirna Jovanović, Amra Ramović, Aleksandrs Pustenko, Raivis Žalubovskisc, Milica Pešić.
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
doi.org/10.1016/j.ejps.2019.105012

sulfocoumarins